Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.3.5.1 (
succinate dehydrogenase
)
8,177
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The morphologic and histochemical effects of 3-nitropropionic acid (NPA) were examined in cultured murine
embryonal carcinoma
cells. NPA caused a dose-dependent inhibition of cell proliferation of cultured murine
embryonal carcinoma
cells at concentrations above 1.05 mM and was lethal at 4.2 mM. Morphologic changes included gross swelling of the cells, swelling of mitochondria and accumulation of organellar debris within the cytoplasm. NPA inhibited the activity of
succinate dehydrogenase
but not of malate, isocitrate or glucose-6-phosphate dehydrogenases, resulting in a decrease in intracellular ATP. Although
succinate dehydrogenase
activity was decreased by NPA, propionic acid and its mercapto-, 2-chloro-, and 3-chloro- derivates did not affect enzyme activity. 3-Nitropropanol also inhibited
succinate dehydrogenase
but only at a much higher concentration than was required with NPA. The results provide evidence that cytotoxicity caused by NPA results from inhibition of
succinate dehydrogenase
activity leading to depression of ATP synthesis. Loss of cellular integrity is probably a direct consequence of failure of energy-dependent cell homeostatic mechanisms such as the plasma membrane Na+/K+ pump, resulting in swelling and ultimately lysis of the cell.
...
PMID:3-Nitropropionic acid toxicity in cultured murine embryonal carcinoma cells. 770 53